Rajendra Institute of Medical Sciences (RIMS) in Ranchi will function as a centre of excellence to help the state combat a possible third wave of Covid-19 with three of its key departments working in tandem to monitor paediatric cases reported frm across the state, health officials said on Thursday.
In a letter addressed to RIMS Director Dr Kameshwar Prasad, state health secretary Arun Kumar Singh stated that the department of neonatology, department of paediatrics and Centre of Excellence for Management of SAM (Severely Acute Malnourished) Children would provide technical guidance for combatting Covid-19 cases among children and prepare protocols and guidelines.
India News: NEW DELHI: Even before ICMR dropped plasma therapy from the Covid treatment protocol, asking hospitals seeking convalescent plasma to fill up a form d.
Why plasma therapy? Seeking details cut down requests for blood at RIMS | India News indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Jamshedpur/Ranchi: Prominent Covid-19 hospitals in Jharkhand are a divided lot over the Indian Council of Medical Research’s (ICMR) advisory on withdrawing plasma therapy.
While Jamshedpur-based Tata Main Hospital (TMH) stopped providing patients with the therapy from Tuesday, Ranchi’s Rajendra Institute of Medical Sciences (Rims) has sought an opinion for its expert committee to plan its future course of action.
“Adhering to the ICMR advisory, issued on Monday late evening, we have stopped providing plasma therapy to Covid-19 patients admitted in our hospital from today (Tuesday),” Dr Rajan Chaudhary, advisor (medical services) to TMH, told TOI.
The ICMR had recommended scrapping of plasma therapy from the current treatment protocol of Covid-19 patients stating that it has no significant benefits on the treatment. TMH is the largest hospital treating Covid-19 patients in East Singhbhum and the entire Kolhan division.